Briefly, depleting antibodies were incubated with red blood cell lysed splenocytes and lymph node cells for 30 min at 4°C. Unbound antibody was washed and the antibody-coupled cells were incubated with BioMag goat anti-rat IgG beads (Qiagen) to deplete CD8 + T cells and B cells.
CD25-biotin antibody (7D4, eBioscience) was used to positively select Treg cells from the CD8-and B cell-depleted cell suspensions. Treg cells were cultured using plate bound anti-CD3 (5 µg/ml, 145-2C11), soluble anti-CD28 (2 µg/ml, 37.51) antibodies and 100 U/ml IL-2 (R&D Systems) as previously described. Treg cells were stimulated with TNF and/or ligands for GITR,
OX-40 or 41-BB (R&D systems) at a concentration of 50 ng/mL. For Western blots to analyze
RelA phosphorylation, Treg cells were stimulated with indicated TNFRSF ligands for 30 mins and for nuclear RelA 90min. To assess RORgt upregulation in splenic Treg cells, we purified CD25 + cells as described and cultured them in the presence of IL-2 (100 U), IL-6 (0.5 µg/mL) and IL-23
(10 µg/ml) for 3-4 days. For iTreg cell cultures and CD4 T cells cultures, naïve CD4 + T cells from WT or Rela fl/fl Lck Cre mice were purified using the naïve CD4 T cell isolation kit (mouse) from Miltenyi Biotec. Cells were cultured at a density of 200,000 cell/well in anti-CD3 antibody coated 48 well flat bottom plates in the presence of anti-CD28 antibody (2 µg/ml), IL-2 (100 U) and TGFb µg/ml) for 4 days.
Nuclear/cytoplasmic protein fractionation. Cells were lysed in cytosolic lysis buffer (10 mM HEPES.KOH, pH7.9, 10 mM KCl and 1.5 mM MgCl2) for 15 min on ice. 10% NP-40 was added (for 50 µl lysis buffer 3.1 µl 10% NP-40), vortexed for 15 sec and spun for 30 sec at 13,000 rpm in a chilled centrifuge. The supernatant containing cytosolic fraction was saved and the nuclear pellet was lysed with 2% SDS in 66 mM Tris (pH7.0) on a heat block for 5 min, spun at 13,000 rpm for 5 min and supernatant saved. Immunoblotting. Cell lysate or nuclear/cytoplasmic fractions were resolved on 4-12% gradient polyacrylamide gels (NuPAGE, Life Technologies), transferred to nitrocellulose membranes (BioRad), and blocked for 1 h with 3% BSA. Immunoblotting was performed using the primary antibodies as specified.
Histology. Formaldehyde fixed tissue sections were stained using Hematoxylin and eosin and the slides were scanned using Aperio (Leica).
Chromatin Immunoprecipitation (ChIP) and bioinformatic analysis. ChIP was performed following an adapted protocol by Upstate/Millipore. In brief, Treg cells isolated from spleens and lymph nodes were stimulated in vitro with anti-CD3 (5 µg/ml), anti-CD28 (1.8 µg/ml) and recombinant hIL-2 (100 U/ml) for 48 h. Cross-linking was done by addition of 1% paraformaldehyde at 22°C for 10 min, followed by sonication and immunoprecipitation with 10 µg of anti-IRF4 (clone sc-6059, Santa Cruz Technologies) and a corresponding goat polyclonalIgG control (clone sc-2028, Santa Cruz Technologies). For RelA ChIP, Treg cells were prepared the same manner but stimulated with PMA/ionomycin for 30 mins before cross-linking. Anti-RelA antibody (SC-372X, Santa Cruz Technologies) was used for immunoprecipitation.
Sequence reads were mapped to mouse genome GRCm37/mm9 using the Subread aligner (Liao et al., 2013) . Only uniquely mapped reads were retained. Binding peaks were called using the (Ritchie et al., 2015) . Genes were excluded from downstream analyses if they failed to achieve 8 reads per kilobase per million in at least one sample. Additionally, genes without current annotation, immunoglobulin genes and those that are sex linked were removed. The removal of sex-linked genes eliminates gender biases from the analysis allowing the two samples in each group to be treated as biological replicates.
Compositional differences between libraries were normalized using the trimmed mean of log expression ratios ( 
Rela fl/fl Foxp3
Cre bone marrow) using the same method described in the previous section. For WT and RelA-deficient Treg cell RNAseq analysis, sequencing reads were mapped to mouse genome GRCm38/mm10 using the Subread aligner and only uniquely mapped reads were retained (Liao et al., 2013) . Genewise counts were obtained using featureCounts (Liao et al., 2014) . Reads overlapping exons in annotation build 38.1 of NCBI RefSeq database were included. Genes were filtered from downstream analysis if they failed to achieve a CPM (counts per million mapped reads) value of greater than 0.5 in at least two libraries. Counts were converted to log2 counts per million, quantile normalized and precision weighted with the 'voom' function of the limma package (Ritchie et al., 2015) . A linear model was fitted to each gene, and empirical Bayes moderated t-statistics were used to assess differences in expression (Smyth, 2004 
not significant (unpaired t-test).
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